Biohit Oyj (HEL:BIOBV)

Finland flag Finland · Delayed Price · Currency is EUR
2.530
+0.030 (1.20%)
Mar 4, 2026, 12:13 PM EET
-11.54%
Market Cap 37.99M
Revenue (ttm) 15.70M
Net Income (ttm) 2.70M
Shares Out 15.20M
EPS (ttm) 0.18
PE Ratio 14.06
Forward PE 16.67
Dividend n/a
Ex-Dividend Date n/a
Volume 1,565
Average Volume 18,542
Open 2.480
Previous Close 2.500
Day's Range 2.470 - 2.530
52-Week Range 2.351 - 3.780
Beta 0.55
RSI 29.73
Earnings Date Feb 11, 2026

About Biohit Oyj

Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company’s diagnostic tests product includes the GastroPanel Unified test panel for stomach health check; GastroPanel Four-in-One stomach test; GastroSoft software application to assist clinicians and general practitioner; BIOHIT Active B12, a test for measuring the concentration of total vitamin-B12 in the serum; BIOHIT Total 25OH Vit... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1988
Employees 46
Stock Exchange Nasdaq Helsinki
Ticker Symbol BIOBV
Full Company Profile

Financial Performance

In 2025, Biohit Oyj's revenue was 15.70 million, an increase of 9.92% compared to the previous year's 14.28 million. Earnings were 2.70 million, an increase of 5.14%.

Financial Statements

News

There is no news available yet.